Repro Med Correlations
| KRMD Stock | USD 4.37 0.19 4.17% |
The current 90-days correlation between Repro Med Systems and STRATA Skin Sciences is 0.14 (i.e., Average diversification). The correlation of Repro Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Repro Med Correlation With Market
Weak diversification
The correlation between Repro Med Systems and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Repro Med Systems and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Repro Stock
Moving against Repro Stock
| 0.76 | IVF | INVO Fertility Symbol Change | PairCorr |
| 0.65 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.6 | IHC | Inspiration Healthcare | PairCorr |
| 0.36 | AHG | Akso Health Group | PairCorr |
| 0.35 | IMDX | Insight Molecular Symbol Change | PairCorr |
| 0.31 | AHC | Austco Healthcare | PairCorr |
| 0.59 | MODD | Modular Medical | PairCorr |
| 0.52 | NVNO | enVVeno Medical Corp | PairCorr |
| 0.5 | TNONW | Tenon Medical Warrant | PairCorr |
| 0.47 | NGMD | NuGen Medical Devices | PairCorr |
| 0.36 | POCI | Precision Optics | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Repro Stock performing well and Repro Med Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Repro Med's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| IINN | 3.19 | (0.75) | 0.00 | (0.53) | 0.00 | 6.86 | 15.99 | |||
| PTHL | 5.52 | 0.28 | 0.03 | 0.94 | 6.77 | 6.56 | 136.77 | |||
| BMRA | 2.51 | (0.20) | 0.00 | (0.13) | 0.00 | 4.37 | 18.44 | |||
| HSCS | 4.21 | 0.42 | 0.06 | 6.93 | 4.84 | 11.07 | 26.18 | |||
| SSKN | 4.56 | (1.68) | 0.00 | (0.36) | 0.00 | 7.56 | 18.95 | |||
| APVO | 4.77 | (1.95) | 0.00 | (1.20) | 0.00 | 7.81 | 43.37 | |||
| ADVB | 4.00 | (0.76) | 0.00 | (0.55) | 0.00 | 8.11 | 28.22 | |||
| BNR | 7.84 | 1.72 | 0.23 | 0.62 | 6.90 | 18.91 | 50.29 |
Repro Med Corporate Management
| Brian Case | Chief Officer | Profile | |
| Thomas Adams | Chief Officer | Profile | |
| Rob Cannon | Interim Officer | Profile | |
| Josh Bennett | VP Devel | Profile | |
| Kenneth Miller | Chief Officer | Profile | |
| Tom Adams | Interim Officer | Profile |